| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADCY10
|
adenylate cyclase 10 (soluble)
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADCY8
|
adenylate cyclase 8 (brain)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKAP1
|
A kinase (PRKA) anchor protein 1
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKAP5
|
A kinase (PRKA) anchor protein 5
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANGPT4
|
angiopoietin 4
|
|
APOA1
|
apolipoprotein A-I
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP5
|
aquaporin 5
|
|
AQP8
|
aquaporin 8
|
|
AREG
|
amphiregulin
|
|
ARG2
|
arginase 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A4
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BVES
|
blood vessel epicardial substance
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCRL
|
calcitonin receptor-like
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASR
|
calcium-sensing receptor
|
|
CATSPER1
|
cation channel, sperm associated 1
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDX2
|
caudal type homeobox 2
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHAMP1
|
chromosome alignment maintaining phosphoprotein 1
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CSK
|
c-src tyrosine kinase
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
DAXX
|
death-domain associated protein
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DRD3
|
dopamine receptor D3
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EP300
|
E1A binding protein p300
|
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FDX1
|
ferredoxin 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXD2
|
forkhead box D2
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GCG
|
glucagon
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAS
|
GNAS complex locus
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR119
|
G protein-coupled receptor 119
|
|
GPR132
|
G protein-coupled receptor 132
|
|
GPR4
|
G protein-coupled receptor 4
|
|
GPR68
|
G protein-coupled receptor 68
|
|
GRK1
|
G protein-coupled receptor kinase 1
|
|
GRK7
|
G protein-coupled receptor kinase 7
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBG1
|
hemoglobin, gamma A
|
|
HBG2
|
hemoglobin, gamma G
|
|
HCN1
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1
|
|
HCN3
|
hyperpolarization activated cyclic nucleotide gated potassium channel 3
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC5
|
histone deacetylase 5
|
|
HDAC9
|
histone deacetylase 9
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIPK3
|
homeodomain interacting protein kinase 3
|
|
HIST2H3A
|
histone cluster 2, H3a
|
|
HRH2
|
histamine receptor H2
|
|
HRH4
|
histamine receptor H4
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IER3
|
immediate early response 3
|
|
IFNG
|
interferon, gamma
|
|
IL10
|
interleukin 10
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL36G
|
interleukin 36, gamma
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KNG1
|
kininogen 1
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LEP
|
leptin
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LINC00473
|
long intergenic non-protein coding RNA 473
|
|
LPA
|
lipoprotein, Lp(a)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPT
|
microtubule-associated protein tau
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MIR125B1
|
microRNA 125b-1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MRAP
|
melanocortin 2 receptor accessory protein
|
|
MSN
|
moesin
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYCBP2
|
MYC binding protein 2, E3 ubiquitin protein ligase
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEUROG1
|
neurogenin 1
|
|
NME7
|
NME/NM23 family member 7
|
|
NOLC1
|
nucleolar and coiled-body phosphoprotein 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NTN1
|
netrin 1
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORM1
|
orosomucoid 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY13
|
purinergic receptor P2Y, G-protein coupled, 13
|
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1
|
|
PDE10A
|
phosphodiesterase 10A
|
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE8A
|
phosphodiesterase 8A
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PEX5L
|
peroxisomal biogenesis factor 5-like
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PNPLA6
|
patatin-like phospholipase domain containing 6
|
|
POMC
|
proopiomelanocortin
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRL
|
prolactin
|
|
PROKR2
|
prokineticin receptor 2
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2
|
|
RANBP2
|
RAN binding protein 2
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
|
RASD2
|
RASD family, member 2
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RDX
|
radixin
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RETN
|
resistin
|
|
RFC2
|
replication factor C (activator 1) 2, 40kDa
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RLN2
|
relaxin 2
|
|
RLN3
|
relaxin 3
|
|
RND3
|
Rho family GTPase 3
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
RXFP3
|
relaxin/insulin-like family peptide receptor 3
|
|
S100A7
|
S100 calcium binding protein A7
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SERBP1
|
SERPINE1 mRNA binding protein 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFTPA1
|
surfactant protein A1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC36A1
|
solute carrier family 36 (proton/amino acid symporter), member 1
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC8A3
|
solute carrier family 8 (sodium/calcium exchanger), member 3
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STIM1
|
stromal interaction molecule 1
|
|
SUCNR1
|
succinate receptor 1
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
SYT1
|
synaptotagmin I
|
|
TAF5L
|
TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF3
|
transcription factor 3
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGM2
|
transglutaminase 2
|
|
TNF
|
tumor necrosis factor
|
|
TNP1
|
transition protein 1 (during histone to protamine replacement)
|
|
TP53
|
tumor protein p53
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
UCN
|
urocortin
|
|
USF1
|
upstream transcription factor 1
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
|
VSNL1
|
visinin-like 1
|
|
XBP1
|
X-box binding protein 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
ZCCHC12
|
zinc finger, CCHC domain containing 12
|
